gsdm: past present & future

55
GSDM: PAST PRESENT & FUTURE RM Clemmons, DVM, PhD, CVA, CVFT Gainesville, FL

Upload: eagan

Post on 24-Feb-2016

41 views

Category:

Documents


0 download

DESCRIPTION

GSDM: Past Present & future. RM Clemmons, DVM, PhD, CVA, CVFT Gainesville, FL. German Shepherd Degenerative Myelopathy (GSDM). A chronic, progressive neurodegenerative disease Initial signs are due to TL spinal cord disease Represents an autoimmune disorder. Signalment. Breeds - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: GSDM:  Past Present & future

GSDM: PAST PRESENT & FUTURE

RM Clemmons, DVM, PhD, CVA, CVFTGainesville, FL

Page 2: GSDM:  Past Present & future

German Shepherd Degenerative Myelopathy

(GSDM) A chronic, progressive

neurodegenerative disease

Initial signs are due to TL spinal cord disease

Represents an autoimmune disorder

Page 3: GSDM:  Past Present & future
Page 4: GSDM:  Past Present & future

Signalment

Breeds German Shepherd dogs Belgium Shepherds Old English Sheepdogs Rhodesian Ridgebacks Weimaraner Probably Great Pyrenes

Age > 5 years old (usually 8-

9)

Sex Equal

Onset 1 month to 1 year

Clinical Course Paralysis within 3

to 6 month without treatment

Page 5: GSDM:  Past Present & future

Signs of GSDM

Page 6: GSDM:  Past Present & future

Histopathology

Axon and myelin loss Swollen axons Patchy demyelination

Astrocyte proliferation

Increase in vasculature

Page 7: GSDM:  Past Present & future

Diagnosis1. Physical and Neurologic Examination

History of chronic progressive posterior paresis in susceptible breed

TL (non-localized) dysfunction

2. Negative Neural Imaging3. Normal Electrodiagnostic Exam

Might have altered spinal evoked response

4. Abnormal CSFLumbar CSF changes

Page 8: GSDM:  Past Present & future

Greta

Signalment

8 yr F/S GSD Weakness Posterior Paresis

S

Page 9: GSDM:  Past Present & future

Greta History

Seemed to be slower over last 6 months Trouble getting up

Vet checked for HD Minimal response to

NSAIDs

Worse over last 30 daysS

Page 10: GSDM:  Past Present & future

Greta

Page 11: GSDM:  Past Present & future

Greta Neurologic Examination

Head- -NAF CN- -NAF Mild Neck Pain (C6) Forelegs- -NAF (slight

dysmetria) Rear Legs-

Slight hyperflexia L>R CP deficits Bilaterally Babinski L Hypermetria

Mild Back Pain (TL)

O

Page 12: GSDM:  Past Present & future

Greta Localization of

Lesion D A M N N I I I T T VO

T3-L3 Spinal Cord

IVDD, GSDM

MyelitisGME

Spinal Tumor

Page 13: GSDM:  Past Present & future

Greta Differential Dx

?

Diagnostic Approach ?

Treatment ?

P

• Problem List1. Posterior Paresis

2. Foreleg Hypermetria

3. Neck & Back Pain

1. GSDM2. IVDD3. Infect/Inflamm4. Neoplasia

Page 14: GSDM:  Past Present & future

Greta- -Diagnostic Approach

MDB CBC Chemistry Profile UA Chest & Abdominal

Radiographs Abdominal Ultrasound

Neurologic Tests EMG CSF Analysis

Cisternal Lumbar

MRI (Whole Spine)

Client EducationP

Page 15: GSDM:  Past Present & future

Greta- -Blood work & UA Unremarkable

O

Page 16: GSDM:  Past Present & future

Greta- -Chest Rads

O

Page 17: GSDM:  Past Present & future

Greta- -Abdominal Rads

O

Page 18: GSDM:  Past Present & future

Greta- -Abdominal Ultrasound

O

Page 19: GSDM:  Past Present & future

Greta

Differential Dx ?

Diagnostic Approach ?

Treatment ?

P

Page 20: GSDM:  Past Present & future

Humeral Immunity

Circulating Immune-complexes 59.3 + 2.5 µg/ml

(normal = 18.7 + 2.5 µg/ml)

Contain non- specific inflammatory proteins on electrophoresis

Page 21: GSDM:  Past Present & future

Cell-Mediated Immunity

Attenuated Response to Mytogens ConA Polkweed Mitogen PHA

Circulating Suppressor Cells

Page 22: GSDM:  Past Present & future

Greta- -EMG Needle EMG normal NCV 55 m/sec F wave present RNS- -nondecremental SEP- -abnormal

O

Greta

Page 23: GSDM:  Past Present & future

Spinal Cord Evoked Potential

NormalEarly DMLate DM

Page 24: GSDM:  Past Present & future

Greta- -CSF Analysis Cisternal CSF

Color/Transparency clear

Protein mg/dL 15

RBC/μL 1

WBC/μL 1

A cell differential count yielded the following: 1% Neutrophils 89% Lymphocytes 10% Mononuclear phagocytes

Interpretation: Benign CSF

Lumbar CSF

Color/Transparency clear

Protein mg/dL 65

RBC/μL 15

WBC/μL 2

A cell differential count yielded the following: 1% Neutrophils 85% Lymphocytes 14% Mononuclear phagocytes

Interpretation: Albuminocytologic

dissociationO

Page 25: GSDM:  Past Present & future

CSF Cholinesterase

normal DM inflam

*

*

O

• Greta• AO- - 250 IU/ml• Lumbar- - 560 IU/ml

Page 26: GSDM:  Past Present & future

Lumbar IgG Concentration

IgG

con

cent

ratio

n

DM normal

Page 27: GSDM:  Past Present & future

Oligoclonal Bands of IgG

Page 28: GSDM:  Past Present & future

Oligoclonal Bands of IgG

Page 29: GSDM:  Past Present & future

2-D Electrophoresis of CSF

Normal DM

Page 30: GSDM:  Past Present & future

CSF Inflammatory Markers

ICAM IL6 NSE Ubiq. S100 Neop.DM Mean 1.5 1.2 1.1 0.9 0.4 1.1

SD 0.7 0.6 0.7 0.9 0.5 1.0Freq. 0.9 0.9 0.8 0.6 0.4 0.7

NIFD Mean 0.8 0.3 0.7 0.3 0.2 0.8SD 0.8 0.8 0.5 0.8 0.4 1.0

Freq. 0.7 0.2 0.7 0.2 0.2 0.5

Page 31: GSDM:  Past Present & future

MBP assay in CSF

GSDM: 4.28 ng/ml ± 2.36

Non-Infam. ND: 0.63 ng/ml ± 0.86

(t>0.05) M

BP0

2.5

5

7.5

10

DM cont

trt

Oneway Analysis of MBP By trt

Page 32: GSDM:  Past Present & future

MBP/TP ratio in CSF

GSDM: 0.092 ± 0.048

Non-Inlfam. ND: 0.024 ± 0.020

(t>0.05)m

bp/tp

0

0.025

0.05

0.075

0.1

0.125

0.15

DM cont

trt

Excluded Rows 1

Oneway Analysis of mbp/tp By trt

Page 33: GSDM:  Past Present & future

Greta- -MRI Lumbar

O

Page 34: GSDM:  Past Present & future

Greta- -MRI Thoracic

O

Page 35: GSDM:  Past Present & future

Greta- -MRI Cervical

O

Page 36: GSDM:  Past Present & future

Greta- -Assessment MDB was essentially normal

Mild HD/hepato- -splenomegaly

EMG demonstrated alterations consistent with spinal white matter conduction delay

CSF showed TL Albuminocytologic dissociation consistent with chronic degenerative prosess

MRI did not reveal significant structural disease

A

Page 37: GSDM:  Past Present & future

Greta- -DM Flash Test

Results came back POSITIVE 96% sensitivity 99% specificity

1 2 3 4 5 6 7 8

Figure 3. DM Flash test. 1-4 are GSDM patients while 5-8 are GSD patients with other neurological diseases.

O

Page 38: GSDM:  Past Present & future

GRETA- -FINAL DIAGNOSISGerman Shepherd Dog

Myelopathy

A

Page 39: GSDM:  Past Present & future

Current Hypothesis

An Auto-Immune CNS Disease Immune-complexes damage endothelium Leads to perivascular fibrin deposition Fibrin degradation leads to leukocyte infiltration Leukocytes produce prostaglandins and

leukotreines Leads to Free-Radical production and damage

Treatment must take these steps into account

Page 40: GSDM:  Past Present & future

Comparison of GSDM & PPMS

GSDM Progressive spinal cord

disease with myelin & axonal loss

No sex predilection

Occurs in 4-6th decade of life

Course is 7-10 years

CSF oligoclonal IgG

Non-plaque forming

Increased CSF MBP

PPMS Progressive spinal cord

disease with myelin & axonal loss

No sex predilection

Occurs in 4-6th decade of life

Course is 7-10 years

CSF oligoclonal IgG

Non-plaque forming

Page 41: GSDM:  Past Present & future

Greta- -Client Education May expect gradual return to function

expecting 80% of recovery in 3 months

May continue to progress over 12-18 months

Need to monitor spleen and blood work every 6 months

Reassess as needed, changing medications when appropriateP

Page 42: GSDM:  Past Present & future

Greta- -TCVM exam Tongue

Pale Wet

Pulse Weak bilaterally

Sensitivity GB 21 BL 18 BL 23

TCVM Diagnosis

Combined Qi/Yin Deficiency with Stagnation

Page 43: GSDM:  Past Present & future

Treatment

Exercise

20-30 minutes twice a week

1 hour once a week

sustained aerobic exercise is needed

CNS O2 delivery

Page 44: GSDM:  Past Present & future

Treatment

Dietary Considerations

Tofu Fresh vegetables

carrots greens peppers broccoli

Ginger, garlic & mustard

Page 45: GSDM:  Past Present & future

Treatment

Supplements

Antioxidants Membrane stabilizers Tonics Anti-inflammatory

Page 46: GSDM:  Past Present & future

Treatment

Medication

Aminocaproic acid (500 mg TID)

n-Acetylcysteine (25 mg/kg TID QD for 2 weeks, then TID QOD)

Page 47: GSDM:  Past Present & future

Conclusion Degenerative Myelopathy appears to be

an Autoimmune Disease and Treatment must be directed at this Process.

Exercise Diet Supplements Medication

Things that CNS O2 Availability

Page 48: GSDM:  Past Present & future

TCVM for GSDM Treat what you see

Most cases present with Wei syndrome secondary to combined Qi & Yin Deficiency

Special AP BL-62

Herbals Di Huang Yin Zi Tang (Rehmannia Decoction) Hu Qian Tang (Hidden Tiger Powder)

Page 49: GSDM:  Past Present & future

Di Huang Yin Zi Tang(Rehmannia Decoction)

Shu Di Huang 10 gm Shan Zhu Yu 10 gmRou Cong Rong 10 gmBa Ji Tian 10 gm Fu Zi 10 gm Rou Gui - An Nan 10 gmShi Hu – fine 10 gmMai Men Dong 10 gmShi Chang Pu 10 gm Yuan Zhi 10 gmFu Ling – curled 10 gm Wu Wei Zi 10 gm

Powder herbs and mix thoroughly. Dosage is 0.5 gm/10lbs for 2 weeks and then 1 gm/10lbs.

Page 50: GSDM:  Past Present & future

Di Huang Yin Zi Tang(Rehmannia Decoction)

Rx Principle:Nourish and tonifies kidney yin; strengthens kidney

water to pacify heart fire; warm and tonifies kidney yang; and strengthen bones and sinews of lower back.

Indications:Stiffness of tongue and hoarse voice; andparalysis of

lower extremities. Dry mouth without thirst and deep weak pulses.

Contraindications:Excess conditions with rising yang.

Page 51: GSDM:  Past Present & future

Hu Qian Tang (Hidden Tiger Powder)

Jiu Chao Huang Bai 150 gmJiu Chao Zhi Mu 30 gmShu Di Huang 60 gmSu Zhi Gui Ban 120 gmBai Shao 60 gmHu Gu 60 gm (Substitute Chuan Niu

Xi)Suo Yang 45 gmGan Jiang 15 gmChen Pi 60 gm

Powder herbs and mix thoroughly. Dosage is 0.5 gm/10lbs for 2 weeks and then 1 gm/10lbs.

Page 52: GSDM:  Past Present & future

Hu Qian Tang (Hidden Tiger Powder)

Rx Principle:Nourishes yin; causes fire to descend; and strengthens bones

and sinews. Treats a atrophy disorders by drying the damp and strengthening the kidney.

Indications:Weakness in lower back and knees; deterioration of the

sinews and bones with general reduction of function; wasting of muscle of the rear legs and feet; and difficult walking. Associated with red tongue and deep, weak pulses.

Contraindications:Not for atrophy due to spleen and stomach deficiency or

invasion of damp-heat.

Page 53: GSDM:  Past Present & future

Greta- -TCVM Therapy AP

Cervical points BL10 GB 21

Lumbar points GV 14 Bai Hui (EA & Moxa) BL40 BL62

Other points ST 36 SP 6 LI 10 LIV 3

Herbal

Hu Qian Tang Walking Tiger

Formula Jing Tang

Di Huang Yin Zi Rehmannia Formula

for Paralysis Jing Tang

Page 54: GSDM:  Past Present & future

GSDM Future Stem Cell Therapy

Currently temporary effects

Epimedium Powder Spinal EA

Polypeptides Neuroregenerative

Peptide Gelsolin

Improved Diagnostics Alternatives to

SOD1 Perhaps altered

ubiquitin pathway

Page 55: GSDM:  Past Present & future